Filing Details
- Accession Number:
- 0001203311-21-000044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-04 20:22:19
- Reporting Period:
- 2021-06-03
- Accepted Time:
- 2021-06-04 20:22:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-03 | 800 | $15.46 | 716,009 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-03 | 800 | $147.71 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-03 | 3,866 | $15.46 | 719,075 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-03 | 3,866 | $147.00 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-03 | 4,551 | $15.46 | 719,760 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-03 | 4,551 | $145.73 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-03 | 3,900 | $15.46 | 719,109 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-03 | 3,900 | $144.90 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-03 | 8,675 | $15.46 | 723,884 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-03 | 8,675 | $143.81 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-03 | 5,718 | $15.46 | 720,927 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-03 | 5,718 | $142.99 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-03 | 1,843 | $15.46 | 717,052 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-03 | 1,843 | $142.07 | 715,209 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-06-03 | 800 | $0.00 | 800 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-06-03 | 3,866 | $0.00 | 3,866 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-06-03 | 4,551 | $0.00 | 4,551 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-06-03 | 3,900 | $0.00 | 3,900 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-06-03 | 8,675 | $0.00 | 8,675 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-06-03 | 5,718 | $0.00 | 5,718 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-06-03 | 1,843 | $0.00 | 1,843 | $15.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 87,259 | 2021-08-24 | No | 4 | M | Direct | |
| 83,393 | 2021-08-24 | No | 4 | M | Direct | |
| 78,842 | 2021-08-24 | No | 4 | M | Direct | |
| 74,942 | 2021-08-24 | No | 4 | M | Direct | |
| 66,267 | 2021-08-24 | No | 4 | M | Direct | |
| 60,549 | 2021-08-24 | No | 4 | M | Direct | |
| 58,706 | 2021-08-24 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $147.60 to $147.82. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $146.43 to $147.41. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $145.39 to $146.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $144.39 to $145.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $143.39 to $144.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $142.39 to $143.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $141.39 to $142.38 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested at a rate of 25% on 8/24/12 and monthly thereafter until all the options were fully vested on 8/24/15.
Billionaire Hedge Funds
